Viewing Study NCT00063258


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2026-02-20 @ 2:24 AM
Study NCT ID: NCT00063258
Status: TERMINATED
Last Update Posted: 2016-05-09
First Post: 2003-06-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Tarceva Surgery for Resectable Stage IIIA(N2) and IIIB (T4 N2) Non-Small-Cell Lung Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Small Cell Lung Cancer View
None Lung Cancer View
None OSI-774 View
None Tarceva View
None Carboplatin View
None Paclitaxel View
None NSCLC View